EchoIQ Ltd. engages in the development and application of artificial intelligence for the cardiac diagnostics sector, as well as the supply of software used by the health fund and insurance sector. It operates through the Houston WeHave Software and Echo IQ segments. The Houston WeHave Software segment offers products and services across defence and other sectors. The Echo IQ segment focuses on developing artificial intelligence software that aids in predicting Aortic Stenosis heart condition. The company was founded by Richard Charles Anstey on March 31, 2010 and is headquartered in Sydney, Australia.